BUZZ-U.S. STOCKS ON THE MOVE-Dow Chemical, OHR Pharmaceutical
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures dipped on Friday, setting indexes up for a full week of daily declines, as the dollar index added to the previous session's rebound ahead of a speech from Federal Reserve Chair Janet Yellen. Dow Jones industrial average futures were down 0.13 percent at 17,580, S&P 500 futures were down 0.07 percent at 2,047 and Nasdaq 100 futures were down 0.05 percent at 4,308.75.
** OHR PHARMACEUTICAL INC, Thursday close $8.73, -44.44 pct premarket
The company said its experimental eye drug failed the main goal in a mid-stage study as a combination therapy.
** DOW CHEMICAL CO, Thursday close $46.86, +4.25 pct premarket
** OLIN CORP, Thursday close $27.19, +19.53 pct premarket
Dow Chemical said it would separate a large part of its chlorine business and merge it with Olin in a deal that will give Dow control of Olin.
** OREXIGEN THERAPEUTICS INC, Thursday close $7.25, +10.62 pct premarket
The drugmaker said on Thursday that the European Commission granted marketing authorization to the company's obesity drug, Mysimba. Continued...